Sandoz, the global leader in generic and biosimilar medicines announced its share trading on the SIX Swiss Exchange as an independent company.
A spin-off from Novartis, the healthcare company has been present in the Philippines since 2022, across all major therapeutic areas, and employs a total of 179 associates.Now an independent company, Sandoz will continue to be a pioneer in providing access for patients and introducing biosimilars as a revolutionary development in ensuring accessible medicines.
Source: Healthcare Press (healthcarepress.net)
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: MlaStandard - 🏆 20. / 55 Read more »
Source: MlaStandard - 🏆 20. / 55 Read more »
Source: MlaStandard - 🏆 20. / 55 Read more »
Source: MlaStandard - 🏆 20. / 55 Read more »
Source: MlaStandard - 🏆 20. / 55 Read more »
Source: MlaStandard - 🏆 20. / 55 Read more »